ARTICLE SUMMARY:
Much of Hologic's success this year is driven by sales of its COVID-19 tests.
With more than 75% of the current quarter complete, some companies are revising their outlook for 2020 to be more favorable than they were on their last quarterly earnings calls, when the nation was in the midst of a lockdown and no one knew how COVID-19 would play out.
